JTCS Concomitant Website
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Federico Venuta
Erino A. Rendina
Tiziano De Giacomo
Giorgio Furio Coloni
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Venuta, F.
Right arrow Articles by Patterson, G. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Venuta, F.
Right arrow Articles by Patterson, G. A.

J Thorac Cardiovasc Surg 2000;119:682-689
© 2000 The American Association for Thoracic Surgery


CARDIOTHORACIC TRANSPLANTATION

PULMONARY HEMODYNAMICS CONTRIBUTE TO INDICATE PRIORITY FOR LUNG TRANSPLANTATION IN PATIENTS WITH CYSTIC FIBROSIS

Federico Venuta, MDa, Erino A. Rendina, MDa, Giorgio Della Rocca, MDb, Tiziano De Giacomo, MDa, Francesco Pugliese, MDb, Anna Maria Ciccone, MDa, Carmine D. Vizza, MDc, Giorgio Furio Coloni, MDa, G. Alexander Patterson, MD, Sponsor

From the University of Rome "La Sapienza," Departments of Thoracic Surgery,a Anesthesiology,b and Cardiology,c Rome, Italy.

Address for reprints: Federico Venuta, MD, Cattedra di Chirurgia Toracica, Policlinico Umberto I, University of Rome "La Sapienza," Via le del Policlinico, 00100 Rome, Italy (E-mail: Fevenuta{at}tin.it ).

Objective: Lung transplantation is a viable option for patients with cystic fibrosis. The current strategy of selection, based on spirometry and deterioration of quality of life, results in a high mortality on the waiting list. We reviewed the case histories of patients with cystic fibrosis accepted for lung transplantation to ascertain whether pulmonary hemodynamics could contribute to predict life expectancy.
Methods: Forty-five patients with cystic fibrosis were accepted: 11 died on the waiting list (group I), 24 underwent transplantation (group II), and 10 are still waiting (group III). During evaluation we recorded spirometry, oxygen requirement, ratio of arterial oxygen tension to inspired oxygen fraction (PaO 2/FIO 2), arterial carbon dioxide tension (PaCO 2), 6-minute walk test results, right ventricular ejection fraction, echocardiography, and pulmonary hemodynamics. We compared data from group I, II, and III patients. A comparison was also made within group II between the data collected at the time of evaluation and at the time of transplantation to quantify the deterioration during the waiting time.
Results: The waiting time, spirometry, 6-minute walk test results, and right ventricular ejection fraction did not differ among the three groups. A statistically significant difference was found for PaO 2/FIO 2, PaCO 2, mean pulmonary artery pressure, cardiac index, pulmonary arterial wedge pressure, and intrapulmonary shunt between groups I and II. Groups I and III showed statistically significant differences for mean pulmonary artery pressure, PaO 2/FIO 2, and systemic vascular resistance indexed. No differences were observed between groups II and III. The comparison within group II showed a significant deterioration of pulmonary hemodynamics during the waiting time.
Conclusions: Pulmonary hemodynamics are worst in patients dying on the waiting list and deteriorate significantly during the waiting time. They may thus contribute to establish priority for lung transplantation in patients with cystic fibrosis.




This article has been cited by other articles:


Home page
ICVTSHome page
F. Venuta, S. Quattrucci, E. A. Rendina, T. De Giacomo, E. Mercadante, M. Moretti, G. Cimino, and G. F. Coloni
Improved results with lung transplantation for cystic fibrosis: a 6-year experience
Interactive CardioVascular and Thoracic Surgery, March 1, 2004; 3(1): 21 - 24.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
A.R. Glanville and M. Estenne
Indications, patient selection and timing of referral for lung transplantation
Eur. Respir. J., November 1, 2003; 22(5): 845 - 852.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
K. G. Tantisira, D. M. Systrom, and L. C. Ginns
An Elevated Breathing Reserve Index at the Lactate Threshold Is a Predictor of Mortality in Patients with Cystic Fibrosis Awaiting Lung Transplantation
Am. J. Respir. Crit. Care Med., June 15, 2002; 165(12): 1629 - 1633.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
P. Aurora, S.A. Prasad, I.M. Balfour-Lynn, G. Slade, B. Whitehead, and R. Dinwiddie
Exercise tolerance in children with cystic fibrosis undergoing lung transplantation assessment
Eur. Respir. J., August 1, 2001; 18(2): 293 - 297.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2000 by The American Association for Thoracic Surgery.